Literature DB >> 12418442

Catastrophic antiphospholipid syndrome in the intensive care unit.

Gloria E Westney1, E Nigel Harris.   

Abstract

CAPS is characterized by development of widespread microvascular thrombosis. Patients at risk are those with positive aCL or LA factor. Precipitating events, such as infection, trauma, surgical procedures, or reduction in anticoagulation therapy, may contribute to the development of CAPS. Presentation to the ICU can be dramatic, with progressive multiorgan failure and need for rapid institution of life-supporting measures. Cardiopulmonary failure has been the major contributor to mortality. A variety of therapeutic modalities have been used in an attempt to offset the widespread thrombosis and organ damage from high aCL levels. Anticoagulation therapy and high dosages of steroids seem to have a positive effect on survival.

Entities:  

Mesh:

Year:  2002        PMID: 12418442     DOI: 10.1016/s0749-0704(02)00026-x

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  5 in total

1.  Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.

Authors:  R Cervera; J Font; J A Gómez-Puerta; G Espinosa; M Cucho; S Bucciarelli; M Ramos-Casals; M Ingelmo; J-C Piette; Y Shoenfeld; R A Asherson
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

2.  Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case.

Authors:  Panagiota Boura; Savas Papadopoulos; Konstantinos Tselios; Panagiotis Skendros; Olga Dioritou; Georgios Malamis; Pantelis Makris; Nikolaos Lefkos
Journal:  Clin Rheumatol       Date:  2005-05-24       Impact factor: 2.980

3.  Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome.

Authors:  Dimitri Titeca-Beauport; Valery Salle; Loay Kontar; Julien Maizel; Gabriel Choukroun
Journal:  Case Rep Crit Care       Date:  2016-10-19

4.  Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases.

Authors:  David Aguirre-Valencia; Juan Naranjo-Escobar; Iván Posso-Osorio; María Carmenza Macía-Mejía; Ivana Nieto-Aristizábal; Tatiana Barrera; María Alejandra Obando; Gabriel J Tobón
Journal:  Autoimmune Dis       Date:  2019-03-11

5.  Antiphospholipid Antibody Syndrome in Childhood Systemic Lupus Erythematous With a Unique Presentation: A Case Report.

Authors:  Amit R Rup; Arun K Dash; Jyoti Ranjan Behera; Sanjay Kumar Sahu; Rama Krushna Gudu; Gummalla Gyandeep; Moparthi Puramjai; Prasanta Padhan; Mukesh K Jain
Journal:  Cureus       Date:  2022-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.